 2019 novel coronavirus, 2019 NCOV, is the cause of an outbreak of pneumonia in Wuhan, Hubei province of China. The study aims to investigate its epidemiologic history, clinical characteristics, treatment regimens, and prognosis of patients infected with 2019 NCOV during this outbreak. The study collected clinical data from 137 2019 NCOV-infected patients admitted to the respiratory departments of nine tertiary hospitals in Hubei province from December 30, 2019 to January 24, 2020. The majority of patients had normal or decreased white blood cell counts and lymphocytopenia. Lung involvement was present in all cases, with most chest-computed tomography scans showing lesions in multiple lung lobes. Treatment focused on symptomatic and respiratory support, an immunoglobulin G was delivered to some critically ill patients. The risk of death was primarily associated with age, underlying chronic diseases, and median interval from the appearance of initial symptoms to dyspnea. The study concludes that the majority of patients with 2019 NCOV pneumonia present with fever as the first symptom, and most of them still show typical manifestations of viral pneumonia on chest imaging. Interlaged and elderly patients with underlying comorbidities are susceptible to respiratory failure and may have a poorer prognosis. We are article.tv, links in the description below.